首页 | 本学科首页   官方微博 | 高级检索  
     

丙种球蛋白治疗RSV毛细支气管炎的临床及免疫学研究
引用本文:董琳,黄达枢,陈小芳,李昌崇. 丙种球蛋白治疗RSV毛细支气管炎的临床及免疫学研究[J]. 临床儿科杂志, 2001, 19(2): 100-101
作者姓名:董琳  黄达枢  陈小芳  李昌崇
作者单位:温州医学院附属育英儿童医院
摘    要:为评估静脉注射丙种球蛋白(IVIG)治疗呼吸道合胞病毒毛细支气管炎(RSV毛支)的临床疗效及免疫学机理,比较26例IVIG治疗组和30例常规治疗组患儿症状体征消失时间及住院天数,同时检测治疗前后血清白介素6(IL-6)、白介素8(IL-8)及肿瘤坏死因子-α(TNF-α)水平。结果:与常规治疗组相比,IVIG治疗组喘憋和肺部体征消失时间明显缩短(4.0天±1.1天比5.2天±1.4天,5.4天±1.5天比6.5天±1.8天,P分别<0.001和<0.05),而住院天数则无显著差异(9.0天±2.2天比10.3天±3.1天,P>0.05)。治疗前两组患儿血清IL-6、IL-8及TNF-α水平均高于正常对照组;IVIG治疗后3种细胞因子水平明显降低.但与常规治疗组相比无显著差异。结论:细胞因子参与了RSV毛支的发病过程。IVIG治疗有较确切的临床疗效,但单剂(0.25g/kg)对血清细胞因子的抑制作用不明显。

关 键 词:毛细支气管炎 呼吸道合胞病毒 细胞因子 儿童 免疫球蛋白 静脉注射 丙种球蛋白

Clinical effect and immunological mechanism of intraveneous immunoglobulin for the treatment of bronchiolitis induced by respiratory syncytial virus (RSV)
Do ng Lin,Huang Dashu,Chen Xiaofang,Li Changchong. Clinical effect and immunological mechanism of intraveneous immunoglobulin for the treatment of bronchiolitis induced by respiratory syncytial virus (RSV)[J]. The Journal of Clinical Pediatrics, 2001, 19(2): 100-101
Authors:Do ng Lin  Huang Dashu  Chen Xiaofang  Li Changchong
Affiliation:Dong Lin,Huang Dashu,Chen Xiaofang,Li Changchong. Yuying Children's Hos-pital affiliated to Wenzhou Medical College,Wenzhou 325027
Abstract:To evaluate clinical effect and immunological mechanism of intravene ous immunoglobulin (IVIG) for the treatment of bronchiolitis induced by respirat ory syncytial virus (RSV) in infants, the levels of serum interleukin 6 (IL- 6), interleukin 8 (IL-8) and tumor necrosis factor-α (TNF -α) were determined before and after IVIG therapy in 26 cases with IVIG therapy, 30 cases with the conventional therapy and 40 cases as normal controls , respectively. The recovery time of the clinical signs and symptoms and duratio n of hospitalization were also compared between the IVIG group and the conventio nal group. The results showed that the levels of IL-6, IL-8 and TNF-α were significantly higher in two groups before treatment comparin g to normal infants. These cytokines tended to decrease after IVIG therapy altho ugh no significantly difference was observed between the IVIG group and the conv entional group. It was noticed that the recovery time of clinical wheezing and l ung signs were obviously shortened in the IVIG group comparing to the convention a l group (4.0±2.1 Vs. 5.2±1.4days; 5.4±1.5 Vs. 6.5±1.8days, P <0.001, P<0.05). No significantly difference of hospitalization days w as observed between two groups (9±2.2 Vs. 10.3±3.1days, P> 0.05). It is concluded that cytokines involves in the pathogenesis of bronchiolitis ind uced by RSV in infants, and IVIG therapy can be helpful for the improvement of t he clinical situation. However, the inhibitory effect on the production of cytok ines seems not to be obvious when single IVIG therapy is given at a dose of 0.25g/kg.
Keywords:bronchiolitis respiratory syncytial virus (RSV) cytokines immunoglobulin intraveneous immunoglobulin (IVIG)
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号